Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Povidone + benzalkonium chloride is a combination of two antiseptic agents used primarily for topical disinfection and infection prevention. Povidone acts as a carrier for iodine (as in povidone-iodine), which releases free iodine to denature proteins and kill bacteria, viruses, fungi, spores, and protozoa through oxidative damage. Benzalkonium chloride is a quaternary ammonium compound that disrupts microbial cell membranes, leading to cell death; it is effective against bacteria, some viruses, yeast, and fungi. This combination may be found in various topical formulations such as wound cleansers or antiseptic solutions for skin or mucous membrane disinfection[4][5][6][9]. Both agents are widely used due to their broad-spectrum antimicrobial activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone + benzalkonium chloride.